Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Rollercoaster week for Safety Shot, stock surges, shorts stirred

Safety Shot (<a href=NASDAQ: SHOT) stock price " width="1200" height="675">

Little-known wellness and functional beverage company Safety Shot (NASDAQ: SHOT) captured headlines and imagination this week as its stock surged higher on exceptional volume. The small-cap company saw its stock rise triple-digits before falling dramatically on Wednesday but remains green on the week as of Wednesday’s close.

The immense volatility experienced in its shares resulted from several factors: a fresh announcement by the company, technical factors impacting the supply and demand of shares, a short report, and lastly, a response by the company to the short report. 

So, as one might imagine, there’s a lot to unpack with shares of SHOT, as the drink maker has garnered intense attention as of late. With a lot going on behind the scenes, it’s worth taking a closer look at the company to see whether shares of the company have overshot the mark or if it’s just getting started.

What is Safety Shot?

Safety Shot is a wellness and functional beverage company that researches and develops over-the-counter products and intellectual property. The company’s product pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sells its products through third-party physical retail stores and partners.

The company’s stock, SHOT, has an average volume of 6.89 million shares, and currently, the company has a market capitalization of just under $100 million. As of the close on Wednesday, shares were trading in the middle of its 52-week range, between $0.31 and $7.5.

Shares SHOT higher this week

Safety Shot shares surged higher this week after the company announced the West Coast launch of Safety Shot, the first patented beverage on earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. 

CEO Brian John said, “We are super excited to have people try Safety Shot. We have given out thousands of Sample Cans and run hundreds of BAC tests already and have proven that trying Safety Shot is believing in Safety Shot.”

The announcement brought in exceptional trading volume for shares of Safety Shot. On Monday, the stock traded over 23 million shares. Tuesday saw the stock trade over 77 million shares; on Wednesday, it traded over 66 million shares. An incredible amount traded, considering its average daily volume is just over 6 million shares. 

Even more impressive, and what undoubtedly played a significant role in volatility and price movements, was the volume traded relative to the float of SHOT. SHOT has a free float of 21 million shares, meaning that the float could have rotated almost nine times between Monday and Wednesday. Add short sale activity and buy-ins to that intraday, and the ingredients for a short-lived short squeeze exist. 

Those factors likely played a more prominent role in the price appreciation than the company announcement. 

SHOT responds to short report

A short report from Capybara Research sent shares of SHOT tumbling on Wednesday. Capybara made several claims about the beverage maker, including claims about the company’s founders and questioning the legitimacy of its flagship product. 

Safety Shot quickly responded to the short report, calling the information malicious, defamatory, and inaccurate. The company said it plans to take legal action against the short seller and highlighted lawsuits filed against Capybara Research regarding potentially fraudulent articles published about other companies. 

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.